Navigation Links
First Live U.S. Demonstration of Cellvizio GI In Vivo Cellular Imaging Technology to Occur at Johns Hopkins Conference
Date:3/5/2008

PHILADELPHIA, March 5 /PRNewswire/ -- Cellvizio Inc., a leader in in vivo cellular imaging, announced today that the first live U.S. demonstration of its Cellvizio(R) GI technology will be conducted March 10, 2008, during the Johns Hopkins University School of Medicine's Eighth Annual Gastroenterology and Hepatology Viva La Vida Conference.

Cellvizio Inc. is the U.S. subsidiary of Paris-based Mauna Kea Technologies and develops and markets Cellvizio, a fundamentally new endoscopic imaging approach which could improve patient care by eliminating the need for unnecessary biopsies and could enhance the diagnosis of a broad range of diseases via in vivo cellular imaging.

The Cellvizio GI procedure will be performed at the Johns Hopkins Hospital in Baltimore during an endoscopy to assist with the diagnosis of Barrett's esophagus. It will be seen live via satellite by attendees of the conference, which is being held March 10-15 in San Juan, Puerto Rico. Gastroenterologists, surgeons and other healthcare professionals with an interest in gastroenterology and hepatology are participating in the program.

"Cellvizio allows physicians to view live tissue inside the body at the cellular level in real-time with a miniaturized microscope threaded through an endoscope and has the potential to benefit patients by reducing invasiveness while speeding up diagnosis," explained Sacha Loiseau, president, CEO and founder of Mauna Kea Technologies. "For example, a current diagnosis of Barrett's esophagus may require 10 to 50 biopsies to be taken and analyzed by a pathologist off line. The use of Cellvizio during this procedure could help reduce this number significantly by allowing physicians to avoid unnecessary biopsies."

Cellvizio GI is commercially available in Europe and in the United States.

About Mauna Kea Technologies:

Mauna Kea Technologies leads the growing in vivo cellular imaging market enabling physicians to visualize, diagnose and treat pathologies that can not be seen using other imaging techniques. Mauna Kea Technologies' flagship Cellvizio system provides microscopic visualization of mucosal tissue and promises to improve clinical outcomes by increasing the diagnostic yield of existing endoscopic procedures. With over 1000 Cellvizio procedures completed to date, Mauna Kea Technologies is currently focused on the gastroenterology and pulmonology markets. The company plans to expand into other markets in the future. The company also has a distribution agreement with Leica Microsystems to sell products for the Small Animal Imaging market in Europe, the U.S. and Japan. For more information about Mauna Kea Technologies: http://www.maunakeatech.com

About The Conference:

The Eighth Annual Gastroenterology and Hepatology: Viva la Vida conference will provide, through formal lectures, followed by questions and answers, a discussion of various disorders, with an emphasis on recent developments. Participants will be updated on the latest management of GI cancers and approaches for the difficult GI bleeder. Endoscopic imaging and therapies will be demonstrated live from the Johns Hopkins Hospital and University of Puerto Rico by renowned international experts.
For more information:

http://www.hopkinscme.net/CourseDetail.aspx?course_code=80016767

Contact:

Erich Sandoval

Lazar Partners

Tel. 212-867-1773

E-mail: esandoval@lazarpartners.com


'/>"/>
SOURCE Cellvizio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility
2. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
3. Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product
4. Center for Molecular Medicine Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer
5. BSPs New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
6. First Complete Career Service for Life-Science Professionals
7. Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
8. Biopure Announces 2008 First Quarter Financial Results
9. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
10. European Company NovaSecta Joins First Chinese CRO Service Alliance for Drug Discovery Solutions
11. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):